Remove 2018 Remove Diabetes Remove People Management
article thumbnail

FDA approves Novo Nordisk’s Wegovy for cardiovascular risk reduction

Pharmaceutical Business Review

The study, which was initiated in 2018, enrolled 17,604 adults across 41 countries to assess the efficacy of semaglutide 2.4mg in comparison to placebo as an adjunct to standard of care for MACE prevention.

article thumbnail

Blood Sugar, Hashimoto’s, Ozempic, Metformin and Berberine

The Thyroid Pharmacist

There is a known link between Hashimoto’s and type 2 diabetes, with up to 30 percent of those with Hashimoto’s developing the condition. Conversely, patients with type 2 diabetes are at an increased risk of developing a thyroid disorder, especially women. Ozempic is a recent blockbuster drug with benefits for diabetes and weight.